Medicair is a privately-owned Greek pharmaceutical company founded in 1998, operating with vertical integration from development and manufacturing to commercialization. The company offers contract manufacturing services for solid, semi-solid, and liquid dosage forms including OTCs and food supplements. Their manufacturing specialization is in pMDI inhalers, external use sprays, foam sprays, unit dose ampoules, semi-solids, and capsules, with a production capacity of 8 million canisters. They invest over 10% of turnover in R&D and have 80+ INNs and 150+ branded generic products. Medicair also offers product development, licensing, and distribution partnerships globally.
pMDI inhaler manufacturing, nasal/oral spray manufacturing, contract manufacturing of semi-solids, capsules, unit dose ampoules, product development, generic pharmaceuticals
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.